| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SSAB-A.ST
|
104.70 | 31.0B | 6.32 | 0.46 | 1.94 | 17.6% | 8.3% | 82 | 85 | 275.03 | +122.0% | 92 | 0.17 |
|
STERV.HE
|
9.38 | 5.8B | 8.27 | 0.54 | 26.07 | 1.9% | 7.6% | 63 | 44 | 13.39 | +28.7% | 53 | 0.42 |
|
OUT1V.HE
|
5.57 | 2.6B | — | 0.77 | 20.45 | 3.0% | 9.5% | 55 | 38 | 6.28 | +8.3% | 70 | 0.18 |
|
SCA-B.ST
|
107.65 | 69.1B | 21.55 | 0.68 | 17.35 | 4.1% | 8.5% | 54 | 25 | 102.72 | -3.3% | 66 | 0.14 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.